Healthcare Services

Global Oncology Ablation Market Report 2026–2035: Key Forecasts and Growth Areas

February 27, 2026April 15, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the oncology ablation market from 2026–2035 with trusted insights from The Business Research Company

How much is the Oncology Ablation Market valued at in 2026, and what valuation is forecast for 2030?

The oncology ablation market size has witnessed rapid growth in recent years. This market is set to increase from $1.45 billion in 2025 to $1.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.5%. The historical growth of this market is attributable to the rising prevalence of liver, kidney, and lung cancers, an increasing demand for minimally invasive treatments, the growing availability of advanced imaging technologies, the expansion of hospitals and specialty oncology centers, and a greater awareness of ablation as an alternative to surgery.

The oncology ablation market is projected to experience substantial expansion over the upcoming years, reaching a valuation of $2.61 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.4%. This anticipated growth during the forecast period is primarily fueled by several factors, including the development of targeted and individualized ablation treatments, the rising preference for percutaneous and laparoscopic ablation methods, continuous technological improvements in ablation devices, the proliferation of oncology facilities in developing areas, and the increased incorporation of digital platforms for patient care and oversight. Key trends anticipated for this period encompass the greater use of digital solutions for managing oncology ablation procedures, the growing incorporation of AI and machine learning for tumor detection and treatment planning, the expanded application of precision medicine and genomic profiling in ablation treatments, enhanced automation within ablation devices and surgical tools, and the increasing reliance on IoT-enabled monitoring for ablation equipment and patient results.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Drivers Are Influencing The Growth Of The Oncology Ablation Market?

The anticipated rise in cancer diagnoses is poised to drive the expansion of the oncology ablation market. Cancer diagnosis involves identifying and confirming the existence of cancer through medical examinations, imaging techniques, and detailed pathological analysis of tissue samples. This increase in cancer diagnoses can be attributed to multiple factors, such as an aging demographic, improvements in screening programs, heightened public awareness leading to earlier detection, and environmental elements. Oncology ablation serves to treat tumors identified through these diagnoses, offering minimally invasive procedures to eliminate tumors and enhance patient prognoses. For instance, in May 2024, the National Cancer Institute, the US-based federal government’s principal agency for cancer research, estimated around 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers collectively representing approximately 48% of all diagnoses in men. Projections indicate a significant surge in the annual number of new cancer cases to 29.9 million by 2040, highlighting a substantial future growth in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported about 1.9 million new cancer cases diagnosed in the USA in 2022. Therefore, the growing number of cancer diagnoses will be a significant catalyst for the oncology ablation market.

What Segments Are Included Within The Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

Which Market Trends Are Opening Growth Opportunities In The Oncology Ablation Market?

Leading companies in the oncology ablation market are innovating products such as advanced ablation systems that offer improved precision, integrated imaging technologies for real-time guidance, and enhanced safety features. Advanced ablation systems with improved precision are medical devices employing sophisticated technology to accurately target and destroy abnormal tissue, like tumors, while minimizing damage to surrounding healthy tissue. For example, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, secured US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, engineered to manage painful bone metastases and benign tumors such as osteoid osteoma. This enhanced system incorporates notable improvements, including the capability to utilize four internally cooled probes simultaneously, thereby enabling the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Who Are The Primary Competitors In The Global Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

Which Regions Are Poised For Strategic Growth In The Oncology Ablation Market?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Oncology Ablation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Ablation Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/ablation-technology-global-market-report

Tumor Ablation Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Tumor Ablation Therapy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795